COI rules might delay drugs: report

Share this article:
In the name of protecting patients, conflict-of-interest (COI) rules imposed by medical schools and public agencies are actually harming them, according to a report from the Manhattan Institute's Project FDA.
The report, written by author and law professor Richard Epstein, who is a visiting scholar at the right-wing think tank, analyzes the negative impact COI rules have over the medical industry. As the regulations have proliferated, so, Epstein observes, has a “mounting wariness” toward collaboration.
“The pall of suspicion makes it appear that every scientist who works is ‘on the take,'” he notes, evoking Dr. Jerome Kassirer's 2005 book of the same name. “It's a very unhealthy set of tactics in my judgment.”
Surveying the entire medical innovation complex, from NIH to FDA to academic medical centers, the author cites roadblocks that arise from the policies. The FDA, for instance, has started demanding extensive public disclosure of financial ties and payments of experts appointed to its advisory committees. Yet a third of these positions are unfilled.
Such an environment threatens to disrupt the exchange of knowledge, degrade research and delay the provision of medicines and treatments, Epstein concluded: “To me...on average, it's a good investment of public time, money and effort to allow people to work in both camps, and the view that somehow this is impermissible has gone way over the top.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: HealthSpot's teleconnected CEO

Headliner: HealthSpot's teleconnected CEO

Steve Cashman, Founder and CEO, HealthSpot

Recruitment: The New Breed

Recruitment: The New Breed

What do healthcare agencies really want when it comes to potential employees? The answer to that question is in a constant state of flux, as technologies, clients' changing demands and ...

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the September 2014 issue of MM&M, with all text, charts and pictures.